Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen Poesen

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Brain : a Journal of Neurology|October 3, 2023
Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changesSteffi De Meyer, Elena R Blujdea, Jolien Schaeverbeke, et al.
Annals of the Rheumatic Diseases|January 27, 2018
Detection of myositis-specific antibodiesJean-Baptiste Vulsteke, Ellen De Langhe, Kristl G Claeys, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 21, 2011
Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neuronsJoke Dhondt, Eve Peeraer, An Verheyen, et al.
Seminars in Arthritis and Rheumatism|April 8, 2021
Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review: Systematic reviewNele Van Horebeek, Jean-Baptiste Vulsteke, Xavier Bossuyt, et al.
Annals of Clinical and Translational Neurology|September 14, 2019
Serum neurofilament heavy chains as early marker of motor neuron degenerationMaxim De Schaepdryver, Janne Goossens, Steffi De Meyer, et al.
Acta Neuropathologica|August 31, 2020
Dipeptide repeat protein and TDP-43 pathology along the hypothalamic-pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP casesLieselot Dedeene, Evelien Van Schoor, Simona Ospitalieri, et al.
Brain Communications|April 1, 2026
Increased CSF levels of soluble AXL at diagnosis correlate with poor prognosis in patients affected by amyotrophic lateral sclerosisMauro G Spatafora, Jonas Dubin, Teuta Domi, et al.
Brain Communications|July 7, 2025
Plasma vesicle-associated membrane protein 2 and glial fibrillary acidic protein associate with synaptic density in older adults without dementiaSteffi De Meyer, Soha Alali, Maarten Laroy, et al.
Cellular and Molecular Life Sciences : CMLS|March 14, 2022
Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomesMafalda Rizzuti, Valentina Melzi, Delia Gagliardi, et al.
Alzheimer'S Research & Therapy|December 6, 2020
Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosisSteffi De Meyer, Jolien M Schaeverbeke, Inge M W Verberk, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Brain : a Journal of Neurology|October 3, 2023
Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changesSteffi De Meyer, Elena R Blujdea, Jolien Schaeverbeke, et al.
Annals of the Rheumatic Diseases|January 27, 2018
Detection of myositis-specific antibodiesJean-Baptiste Vulsteke, Ellen De Langhe, Kristl G Claeys, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 21, 2011
Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neuronsJoke Dhondt, Eve Peeraer, An Verheyen, et al.
Seminars in Arthritis and Rheumatism|April 8, 2021
Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review: Systematic reviewNele Van Horebeek, Jean-Baptiste Vulsteke, Xavier Bossuyt, et al.
Annals of Clinical and Translational Neurology|September 14, 2019
Serum neurofilament heavy chains as early marker of motor neuron degenerationMaxim De Schaepdryver, Janne Goossens, Steffi De Meyer, et al.
Acta Neuropathologica|August 31, 2020
Dipeptide repeat protein and TDP-43 pathology along the hypothalamic-pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP casesLieselot Dedeene, Evelien Van Schoor, Simona Ospitalieri, et al.
Brain Communications|April 1, 2026
Increased CSF levels of soluble AXL at diagnosis correlate with poor prognosis in patients affected by amyotrophic lateral sclerosisMauro G Spatafora, Jonas Dubin, Teuta Domi, et al.
Brain Communications|July 7, 2025
Plasma vesicle-associated membrane protein 2 and glial fibrillary acidic protein associate with synaptic density in older adults without dementiaSteffi De Meyer, Soha Alali, Maarten Laroy, et al.
Cellular and Molecular Life Sciences : CMLS|March 14, 2022
Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomesMafalda Rizzuti, Valentina Melzi, Delia Gagliardi, et al.
Alzheimer'S Research & Therapy|December 6, 2020
Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosisSteffi De Meyer, Jolien M Schaeverbeke, Inge M W Verberk, et al.
Pageof 9